Cargando…

A New Prognostic Signature Constructed with Necroptosis-Related lncRNA in Bladder Cancer

BACKGROUND: Bladder cancer (BC) accounts for the most common urologic malignancy, leading to a heavy social burden over the world. We aim to search for a novel prognostic biomarker with necroptosis-related lncRNAs of bladder cancer in this study. METHODS: We download the RNA-sequencing data and corr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Zuhu, Lu, Bin, Gao, Hong, Liang, Rongfang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9681547/ https://www.ncbi.nlm.nih.gov/pubmed/36425941 http://dx.doi.org/10.1155/2022/5643496

Ejemplares similares

A novel prognostic signature for clear cell renal cell carcinoma constructed using necroptosis-related miRNAs
por: Yu, Zuhu, et al.
Publicado: (2023)

Construction of an immune‐related LncRNA signature with prognostic significance for bladder cancer
por: Luo, Wen‐Jie, et al.
Publicado: (2021)

Necroptosis-Related LncRNA Signatures for Prognostic Prediction in Uterine Corpora Endometrial Cancer
por: Lin, Zhiheng, et al.
Publicado: (2022)

Construction and Validation of a Necroptosis-Related lncRNA Signature in Prognosis and Immune Microenvironment for Glioma
por: Jiang, Fan, et al.
Publicado: (2022)

Construction of a novel necroptosis-related lncRNA signature for prognosis prediction in esophageal cancer
por: Liu, Yang, et al.
Publicado: (2022)

A Novel Necroptosis-Related lncRNA Signature for Osteosarcoma
por: Zheng, Yixin, et al.
Publicado: (2022)

Construction of an lncRNA model for prognostic prediction of bladder cancer
por: Shi, Changlong, et al.
Publicado: (2022)

Construction of a cuproptosis-associated lncRNA prognostic signature for bladder cancer and experimental validation of cuproptosis-related lncRNA UBE2Q1-AS1
por: Shen, Junlin, et al.
Publicado: (2023)

Necroptosis‐related lncRNA to establish novel prognostic signature and predict the immunotherapy response in breast cancer
por: Chen, Fangyue, et al.
Publicado: (2022)

Necroptosis-related lncRNA signatures determine prognosis in breast cancer patients
por: Zhang, Yuan, et al.
Publicado: (2022)

A Novel Necroptosis-Related lncRNA Signature Predicts the Prognosis of Lung Adenocarcinoma
por: Lu, Yinliang, et al.
Publicado: (2022)

A risk signature of necroptosis-related lncRNA to predict prognosis and probe molecular characteristics for male with bladder cancer
por: Jin, Yuzhou, et al.
Publicado: (2023)

A five necroptosis-related lncRNA signature predicts the prognosis of bladder cancer and identifies hot or cold tumors
por: Li, Han, et al.
Publicado: (2023)

Construction of a prognostic glycolysis‐related lncRNA signature for patients with colorectal cancer
por: Zhong, Xinyang, et al.
Publicado: (2022)

Derivation and Validation of a Necroptosis-Related lncRNA Signature in Patients with Ovarian Cancer
por: Zhu, Linling, et al.
Publicado: (2022)

A Necroptosis-Related lncRNA to Develop a Signature to Predict the Outcome, Immune Landscape, and Chemotherapeutic Responses in Bladder Urothelial Carcinoma
por: Hou, Jian, et al.
Publicado: (2022)

Construction of a necroptosis‐related lncRNA signature to predict the prognosis and immune microenvironment of head and neck squamous cell carcinoma
por: Huang, Juntao, et al.
Publicado: (2022)

Construction of a Necroptosis-Related lncRNA Signature for Predicting Prognosis and Immune Response in Kidney Renal Clear Cell Carcinoma
por: Zhang, Yue, et al.
Publicado: (2022)

Constructing an immune‐ and ferroptosis‐related lncRNA signature to predict the immune landscape of human bladder cancer
por: Li, Xing, et al.
Publicado: (2022)

Identification and validation of a prognostic immune-related lncRNA signature in bladder cancer
por: Zhao, Kai, et al.
Publicado: (2021)

A Novel Necroptosis-Related lncRNA Signature for Predicting Prognosis and Immune Response of Glioma
por: Wu, Zhikang, et al.
Publicado: (2022)

Identification and Validation of the lncRNA MYOSLID as a Regulating Factor of Necroptosis and Immune Cell Infiltration in Colorectal Cancer following Necroptosis-Related LncRNA Model Establishment
por: Wu, Zhiwei, et al.
Publicado: (2022)

Machine learning-based construction of a ferroptosis and necroptosis associated lncRNA signature for predicting prognosis and immunotherapy response in hepatocellular cancer
por: Zhao, Lei, et al.
Publicado: (2023)

Construction of a Novel Prognostic Signature in Lung Adenocarcinoma Based on Necroptosis-Related lncRNAs
por: Diao, Xiayao, et al.
Publicado: (2022)

A pyroptosis‐related lncRNA signature in bladder cancer
por: Wang, Peng, et al.
Publicado: (2022)

Identification of Immune-Related lncRNA Pairs and Construction and Validation of a New Prognostic Signature of Colon Cancer
por: Xu, Minxian, et al.
Publicado: (2022)

Construction and validation of cuproptosis-related lncRNA prediction signature for bladder cancer and immune infiltration analysis
por: Li, Hanrong, et al.
Publicado: (2023)

A potential prognostic lncRNA signature for predicting survival in patients with bladder urothelial carcinoma
por: Bao, Zhenyu, et al.
Publicado: (2017)

Identification and validation of a twelve immune infiltration-related lncRNA prognostic signature for bladder cancer
por: Liu, Chen-Qian, et al.
Publicado: (2022)

A New Ferroptosis-Related lncRNA Signature Predicts the Prognosis of Bladder Cancer Patients
por: Chen, Mei, et al.
Publicado: (2021)

Construction of a Prognostic Model Based on Cuproptosis-Related lncRNA Signatures in Pancreatic Cancer
por: Jiang, Wenkai, et al.
Publicado: (2022)

Identification and Validation of Necroptosis-Related LncRNA Signature in Hepatocellular Carcinoma for Prognosis Estimation and Microenvironment Status
por: Chen, Cong, et al.
Publicado: (2022)

A novel necroptosis-related lncRNA signature for predicting prognosis and immune response of colon cancer
por: Luo, Jian, et al.
Publicado: (2022)

A novel necroptosis-related lncRNA signature predicts the prognosis and immune microenvironment of hepatocellular carcinoma
por: Wang, Jianguo, et al.
Publicado: (2022)

Integrated Analysis of a Competing Endogenous RNA Network Reveals a Prognostic lncRNA Signature in Bladder Cancer
por: Peng, Mou, et al.
Publicado: (2021)

Construction of m6A-Related lncRNA Prognostic Signature Model and Immunomodulatory Effect in Glioblastoma Multiforme
por: Xie, Pan, et al.
Publicado: (2022)

A necroptosis-related lncRNA signature was identified to predict the prognosis and immune microenvironment of IDH-wild-type GBM
por: Song, Chong, et al.
Publicado: (2022)

Construction of lncRNA prognostic model related to cuproptosis in esophageal carcinoma
por: Zhang, Liming, et al.
Publicado: (2023)

Extracellular Matrix–Related Six-lncRNA Signature as a Novel Prognostic Biomarker for Bladder Cancer
por: Qing, Liangliang, et al.
Publicado: (2020)

A Necroptosis-Related lncRNA-Based Signature to Predict Prognosis and Probe Molecular Characteristics of Stomach Adenocarcinoma
por: Luo, Lianghua, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ep7vgcpo0qgr03aa3siihs464d